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ABSTRACT
The aim of this study was to determine, using immunofluorescence and in situ hybridization, whether CAEV is
capable of infecting goat uterine epithelial cells in vivo. Five CAEV seropositive goats confirmed as infected using
double nested polymerase chain reaction (dnPCR) on leucocytes and on vaginal secretions were used as CAEV
positive goats. Five CAEV-free goats were used as controls. Samples from the uterine horn were prepared for
dnPCR, in situ hybridization, and immunofluorescence. The results from dnPCR confirmed the presence of CAEV
proviral DNA in the uterine horn samples of infected goats whereas no CAEV proviral DNA was detected in
samples taken from the uninfected control goats. The in situ hybridization probe was complementary to part of
the CAEV gag gene and confirmed the presence of CAEV nucleic acids in uterine samples. The positively staining
cells were seen concentrated in the mucosa of the lamina propria of uterine sections. Finally, laser confocal analysis
of double p28/cytokeratin immunolabelled transverse sections of CAEV infected goat uterus, demonstrated that the
virus was localized in glandular and epithelial cells. This study clearly demonstrates that goat uterine epithelial cells
are susceptible to CAEV infection in vivo. This finding could help to further our understanding of the epidemiology
of CAEV, and in particular the possibility of vertical transmission.
Introduction
Caprine arthritis-encephalitis virus (CAEV) was first
described as a cause of chronic arthritis in American
goats [1-3], and has since been found to be widespread
in goat herds worldwide [4,5]. CAEV is an RNA virus
belonging to the lentivirus genus of the family retroviri-
dae [1]. In France, the infection is present in around 80
to 95% of breeding herds [6] and causes economic losses
through reduced milk production, early culling, and loss
of export potential [7]. Symptoms of infection may
include lung disease and, more often, indurative mastitis
as well as classical arthritis. Leucoencephalitis in young
kids [1] remains rare.
Infection can be transmitted by any means involving
the transfer of infected cells to a naïve recipient. In the
field, the principal route of transmission is vertical from
dam to kids through colostrum and milk [5], with addi-
tional horizontal transmission following prolonged con-
tact between infected and naïve adult animals [8].
Attempts to reduce infection by treating colostrum and
milk, and separating infected and naïve animals have
been disappointing [8,9], and attempts have been made
to identify other risk factors [10,11].
Although the oral route remains the principal mode of
natural transmission, sexual transmission has yet to be
fully explored. CAEV proviral DNA has been identified
using PCR in tissues of the genital tract (uterus, oviduct,
and ovary [12]), and in uterine flushing media recovered
four days after fecundation [13,14].
The virus primarily infects cells of the monocyte-macro-
phage lineage, with viral production being linked to cell
differentiation from monocytes to macrophages [15,16];
however, viral transcripts have been detected in epithelial
cells in the small intestine, thyroid gland, and kidneys of
infected goats [17]. In vitro, granulosa cells, oviduct
epithelial cells [18,19] and caprine early embryonic cells
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this virus is productive. Nevertheless, no information is
available concerning the phenotype of CAEV infected cells
in the female genital tract. This information would
improve our understanding of the risk of CAEV vertical
transmission in utero or following in vivo as well as in
vitro embryo production and embryo transfer.
The goal of this study was to determine, using immu-
nofluorescence and in situ hybridization, whether CAEV
is capable of infecting uterine epithelial cells in vivo.
Materials and methods
Animals
Five goats that had repeatedly tested seropositive for
CAEV using ELISA, and that were confirmed as positive
using PCR on leucocytes and vaginal secretions, were
used as positive infected goats. Five goats that were
selected from ELISA certified CAEV negative herds and
which had two dnPCR negative blood samples and two
dnPCR vaginal swab samples at an interval of one month
were used as negative control goats.
Samples
The goats were slaughtered in accordance with French
regulations. Immediately prior to slaughter, 8 mL of
blood were drawn from the jugular vein into acid citrate
dextrose.
The uterus was harvested from each animal immediately
after euthanasia and exsanguination. Uterine samples were
taken from each goat from the greater curvature of the
uterine horn and processed in one of three different ways:
for PCR analysis, samples were stored at -80°C. For immu-
nohistochemistry analyses, samples were embedded in
Tissue tek (Sakura Finetek, Torrance, CA, USA) and fro-
zen in isopentane cooled with liquid nitrogen. Transverse
cryosections of uterine horn were prepared with a Leica
CM 3050S cryostat (Leica Microsystems, Nanterre,
France). For in situ hybridization, tissues were fixed in 4%
formaldehyde for 10 min at room temperature and
embedded in paraffin. We used separate scalpel blades for
each goat. When collecting different samples from the
same goat, we washed the scalpel blade in RBS Viro (Fluka
Chemical Corp New York NY, USA), wiped it on a sheet
of absorbent paper, disinfected it with ethanol (70°), and
finally dried it with a new sheet of absorbent paper
between each sample.
PCR analyses
Preparation of the samples for PCR
The whole blood, collected in anticoagulant, was centri-
fuged at 1900 × g for 30 min at room temperature using
Ficoll density-gradient centrifugation. At the end of this
first phase, leucocytes were recovered from the buffy
coat, washed in sterile PBS pH 7.2, and centrifuged for
5 min at 700 × g, three times over. The supernatant was
discarded and the cell pellet was stored at -80°C await-
ing subsequent DNA extraction.
After thawing, DNA was extracted from the leucocytes
and uterine samples using a “QIAamp Tissue kit
®” (Qia-
gen, Courtabœuf, France), in accordance with the manu-
facturer’s instructions. The samples were then stored at
-20°C, awaiting PCR analysis.
Procedure for double nested-PCR
We used the double nested-PCR technique, as described
previously by Barlough et al.[21] to detect CAEV proviral-
DNA in the blood and uterine horn tissue samples. Two
rounds of PCR amplification were used to detect the gag
sequence of the CAEV genome.
In the first round, the virus was detected by amplifying a
fragment of proviral-DNA, located between nucleotide
393 and nucleotide 1291, using external primers GAG
EX5 (5’- GAA GTG TTG CTG CGA GAG GTC TTG -3’)
and GAG EX3 (5’- TGC CTG ATC CAT GTT AGC TTG
TGC -3’). This round was immediately followed by a sec-
ond round, amplifying the fragment located between
nucleotide 524 and nucleotide 1036, using internal primers
GAG IN5 (5’- GAT AGA GAC ATG GCG AGG CAA GT
-3’) and GAG IN3 (5’- GAG GCC ATG CTG CAT TGC
TAC TGT -3’). Oligonucleotide primers specific to the
fourth exon of the human b-actin gene were used as an
internal control for the integrity of the DNA lysates: exter-
nal-ES30 (5’- TCA TGT TTG AGA CCT TCA ACA CCC
CAG -3’) and ES32 (5’- CCA GGG GAA GGC TTG AAG
AGT GCC -3’) for the first round, and internal-ES31 (5’-
CCC CAG CCA TGT ACG TTG CTA TCC -3’)a n d
ES33 (5’- GCC TCA GGG CAG CGG AAC CGC TCA
-3’) for the second round [22].
For the first round of amplification, 10 μL of DNA (con-
taining 0.5 to 1 μg) were added to 40 μL of an amplifica-
tion solution, or “mix1”. The latter was comprised of 5 μL
of reaction buffer [10×] (670 mM Tris/HCl (pH 8.8),
160 mM (NH4)2SO4,0.1% TWEEN-20), 5 μLo fM g C l 2
(50 mM), 1 μL of dNTP (25 mM of each oligonucleotide
triphosphate: dATP, dGTP, dCTP, dTTP), 0.25 μLo f
TAQ Polymerase (5 U/μL, EUROBIOTAQ
® DNA Poly-
merase-Thermostable, GAETAQ02K, EUROBIO, Les Ulis,
France), 0.5 μLe a c ho fp r i m e r sG A GE X 3 ,G A GE X 5 ,
ES30, and ES32 (20 μM, GIBCO BRL Custom primers -
Life Technologies, Grand Island, NY, USA), and 26.75 μL
of DEPC-treated water.
For the second round, 5 μL of the first round were
added to 45 μL of a second amplification solution, or
“mix2” containing the same reagents as the solution in
mixture 1, except that internal primers GAG IN5, GAG
IN3, ES31, and ES33 were used in place of external pri-
mers GAG EX5, GAG EX3, ES30, and ES32. For each
round, following initial denaturation at 94°C for 5 min,
the samples were submitted to a series of 35 cycles
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tion phase at 94°C, a 90-second hybridization phase at
46°C and a 2-and-a-half-minute extension phase at 60°C.
Each round was followed by a final extension at 60°C for
15 min. Amplification products were visualized using
electrophoresis on 1.5% agarose gel (GIBCO LIFE Tech-
nologies, Grand Island, NY, USA), containing Ethidium
Bromide in 1× TAE buffer: 10 μL of the amplified fraction
were added to 5 μL of dyed loading buffer, in each gel
well. Two controls were performed for each gel: a positive
control (CAEV proviral-DNA from infected GSM (goat
synovial membrane)) and a negative control (distilled
water). Five microliters of Smart-Ladder (GIBCO LIFE
Technologies), was used as a molecular weight marker.
This marker comprises 14 bands calibrated between
10 000 and 200 bp. Following electrophoretic separation,
the bands were visualized using transillumination, with
ultraviolet light (312 nm).
In situ hybridization and cytokeratin labeling
In situ hybridization
In situ hybridization was used to detect the presence of
CAEV nucleic acids in the uterine samples. The specificity
of the probe was checked by the observation of in situ
hybridization on two goat synovial membrane cell cultures
infected in vitro with CAEV-3112 [23]. Mammary lymph
node samples from PCR-confirmed CAEV-infected goats
with clinical disease were used as positive controls. Nega-
tive controls included PCR-negative tissues (lymph node
and uterus) and non-infected goat synovial membrane cell
cultures. The absence of non-specific labeling was checked
by omitting the labeled probe in serial sections of positive
tissues (lymph node and uterus) and in goat synovial
membrane cell cultures infected in vitro.
All tissues were paraffin embedded after formalin fixa-
tion, and all solutions used were made with di-ethyl-pyro-
carbonate-treated water to inactivate eventual RNAse con-
tamination. Tissue sections (ca 4 μm) were spread out on
RNAse-free silanized slides [24], covered with PBS pH 7.6
and dried in a hood oven at 37°C for 12 h before being
deparaffinized twice for ten minutes in 1-bromopropane
(LMR-Ground) and re-hydrated through 100%, 95%, 70%
and 30% ethanol baths (5 min each) and distilled water
(30 s). After 3 × 3 min washes in PBS, the sections were
treated with an enhancing solution comprising 62.5 μL
acetic anhydride in 25 mL of 0.1 M triethanolamine pH
8.0 for 10 min, washed in SSC 1× for 5 min, permeabilised
in 0.2 M HCl for 10 min at room temperature, and finally
washed in PBS for 5 min before hybridization.
A probe complementary to viral strand RNA was gen-
erated from the pBSCA plasmid carrying the complete
CAEV genome by PCR amplification of the gag region
using primers GAG EX 5’ and GAG EX 3’. After purifi-
cation with a GeneClean kit (Appligene, Illkirch,
France), the probe was labeled by nick translation [25]
using the Dig-Nick translation kit (Rock GmbH, Man-
nheim, Germany), and unincorporated nucleotides were
removed by passage through Probe Quant T.M.G 50
columns (Amersham, Orsay, France). Labeled probes
were verified by slot-blot determinations on Hybond™
N+ nylon membranes (Amersham, Pantin, France), and
stored at -20°C until use.
Slides were pretreated with 30 μL hybridization mixture
(50% formamide in 5× SSC containing 2% Casein, 0.1 N
N-lauroyl sarcosine and 200 μg/mL sheared denatured sal-
mon sperm) for 1-2 h at 42°C. The labeled probe was
denatured by boiling for 10 min, then cooling on ice
immediately before hybridization. The slides were overlaid
with 30 μL of hybridizing mixture containing 16-32 ng of
labeled probe and preheated to 42°C, covered with cover-
slips, and incubated for 16 h at 42°C in a moist atmo-
sphere. The reaction was terminated by removing the
coverslips and washing the slides in 2× SSC containing
0.1% SDS, twice for 5 min. After two further washes in a
solution containing 1× SSC and 0.1% SDS for 15 min at
42°C and a solution containing 0.1 M malic acid and 0.3%
Tween 20 for 1 min at room temperature, the slides were
blocked with 10% casein in malic acid for 30 min at room
temperature. They were then treated with alkaline phos-
phatase-labeled anti-dioxygenin (1/5000 in blocking solu-
tion) for a further 30 min at room temperature. After two
washes in malic acid for 15 min at room temperature and
rinsing in AP buffer (100 mM Tris HCl, 100 mM NaCl
and 50 mM MgCl2 in water), freshly-prepared chromo-
genic substrate (5-bromo-4-chloro-3-indolylphosphate/
Nitro blue tetrazolium) in AP buffer was added for 10-20
min at room temperature in the dark. After rinsing in dis-
tilled water, the slides were counterstained with Harris
hematoxylin, rinsed in tap water, dehydrated in alcohol,




To identify epithelial cells in uterine sections, adjacent sec-
tions were stained for cytokeratin. The sections were trea-
ted with trypsin (1 mg/mL) for 30 s at 37°C, washed three
times in distilled water, blocked with 3% hydrogen perox-
ide for 10 min, washed in PBS pH 7.6 for 5 min, and then
in normal goat serum (Dako; X.907; 20% in PBS) for
20 min. They were then incubated with a monoclonal anti-
cytokeratin antibody (Dako; M 821: 1/500) in 2% BSA in
PBS for 60 min in a humid chamber, washed three times
in PBS, and incubated with biotinylated goat anti-mouse
IgG (Dako; E.433; 1:300 in PBS) for 30 min at room tem-
perature, then with streptavidin/peroxidase (Dako; P.397;
1:300 in PBS) for a further 30 min at room temperature.
After the final wash, the slides were treated with chromo-
genic reagent (diaminobenzidine; Dako K.3485) for 15 min,
counterstained with Harris hematoxylin, and mounted as
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were used as negative controls and oviductal epithelial cell
cultures as positive controls.
Immunofluorescence and laser scanning confocal analysis
To determine the cellular localization of CAEV in uterine
samples, we tested our primary antibody, IgG1 anti-p28
(CAEP5A1, VMRD, Pullman, USA), on goat synovial
membrane cell cultures (GSM) infected in vitro by CAEV-
3112. GSM are very sensitive to CAEV and therefore con-
stitute a good positive control. Negative controls included
PCR-negative uterine tissues and non-infected GSM cell
cultures. Furthermore, the absence of non-specific labeling
was checked by omitting the primary antibody on positive
uterine tissue. To pinpoint the cellular localization of virus
in uterine tissues, we performed double labeling against
p28 and cytokeratin (N75350, Interchim, Montluçon,
France) as a marker of epithelial cells, in combination with
nuclei staining.
Transverse cryosections of uterine horn (10 μm) were
prepared using a Leica CM 3050S cryostat. Sections were
air dried at room temperature and fixed for 15 min with
acetone at 4°C before being stored at -80°C. Immunolabel-
ing was performed on freshly thawed sections. Sections
were rehydrated with PBS and blocked with 10% donkey
serum diluted in PBS. The mouse anti-p28 monoclonal
antibody was diluted to 1/100 in blocking buffer and sec-
tions were incubated with this primary antibody overnight
at 4°C. After washing, the sections were incubated with
the secondary antibody, Alexa Fluor 555 donkey anti-
mouse, for one hour at room temperature (1/400, A31570,
Invitrogen, France). After washing, the samples were then
fixed with PFA 4% for 15 min at room temperature,
washed in PBS and incubated with a mouse anti-cytokera-
tin monoclonal antibody (N75350, Interchim, Montluçon,
France) overnight at 4°C. Sections were then washed in
PBS and incubated with a secondary antibody, Alexa fluor
488 donkey anti-mouse (A21202, Invitrogen, France).
Nuclei were stained with Topro-3 (1/1000, Invitrogen Life
Technologies, Illkirch, France). Finally, slides were cover-
slipped and mounted with Mowiol Medium (Clabiochem
EMD Biosciences, San Diego, CA, USA). The immunola-
beled sections were serially scanned with a confocal
microscope (Nikon C1, Champigny-sur-Marne, France)
using the 543 nm helium neon laser to observe p28 immu-
nolabeling (red), the argon ion laser (488 nm) to observe
cytokeratin immunolabeling (green), and the 633 nm
helium neon laser to observe stained nuclei (blue).
Results
PCR results
Samples analyzed for CAEV proviral-DNA using PCR
were considered to be positive when a 512 bp band, cor-
responding to the positive control, was seen on agarose
gel electrophoresis under UV light, between the 600 bp
and 400 bp molecular weight bands. Whereas the 393
bp band, generated from the amplification of the endo-
genous actin gene, was present in both non-infected and
CAEV-infected samples.
Nested-PCR amplification using DNA isolated from
white blood cells and uterine samples taken from posi-
tive goats gave clear bands of the expected size (512 bp)
on agar gel electrophoresis. No CAEV proviral DNA
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Figure 1 In situ hybridization of uterine tissues (bar = 10
micrometers). CAEV RNA positive staining (brownish-purple
intracytoplasmic inclusions) could be identified (black arrow) in the














Figure 2 Cytokeratine labeling of figure 1 adjacent section (4
μm). The brown cytokeratin staining (black arrow) identified the
single layer of cuboidal glandular epithelial cell (bar = 10
micrometers).
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Figure 3 Immunofluorescence results after laser scanning confocal analysis of (i) single CAEV p28 labeling (red color) on CAEV
infected and non-infected GSM cells and of (ii) double CAEV p28 (red color) and cytokeratin (green color) labeling on the same
uterine section of CAEV infected and non-infected goats. A: uterine gland from a CAEV infected goat; B: external epithelium of a uterus from
a CAEV infected goat; C: an external epithelium of a uterus from a non infected goat.
Ali Al Ahmad et al. Veterinary Research 2012, 43:5
http://www.veterinaryresearch.org/content/43/1/5
Page 5 of 7In situ hybridization
Hybridizing cells were characterized by the presence of
brownish-purple intracytoplasmic inclusions. The posi-
tively-staining cells were concentrated in the mucosa of
the lamina propria of uterine sections (Figure 1) and the
uterine glands. In the adjacent sections, the glandular
epithelial cells could be distinguished by their cuboid
morphology with nuclei at the lower end, and were con-
firmed by brown cytokeratin staining (Figure 2).
Immunofluorescence
Immunohistochemical analysis of CAEV p28 was per-
formed on infected and non-infected GSM. Specific label-
ing of the virus was observed on CAEV infected GSM
whereas no uptake occurred in healthy GSM. The double
p28/cytokeratin immunolabeling performed on transverse
sections of CAEV-infected goat uterus revealed that the
virus was essentially localized in glandular epithelial cells
and in the external epithelial cells of the uterus. No uptake
was seen in non-infected goat uterus sections (Figure 3).
Discussion
In this study, we investigated the cellular localization of
CAEV in uterine tissues taken from CAEV-infected
goats, using in situ hybridization and immunofluores-
cence with laser scanning confocal analysis.
CAEV infection of uterine tissues was confirmed by the
presence of cells with clear and specific cytoplasmic
hybridization to a CAEV-specific probe. We used a probe
that is a complementary part of the CAEV gag gene; a
detectable reaction requires the presence of several
copies of target sequences. The reaction thus revealed
cytoplasmic concentrations consistent with actively repli-
cating CAEV, and not just nuclear localizations of pro-
viral sequences.
The double immunolabeling against p28 and cytokera-
tin, analyzed using immunofluorescence and laser scan-
ning confocal analysis, clearly demonstrated that uterine
epithelial cells were infected by CAEV in vivo.
In vitro studies have shown that various epithelial cell
types from the goat genital tract, oviduct epithelial cells
[18], and granulosa cells [19], are highly susceptible to
productive infection with CAEV. In other species various
lentiviruses, including Feline Immunodeficiency Virus
(FIV) [26], Simian Immunodeficiency Virus (SIV) [27],
and the Human Immunodeficiency Virus (HIV-1) [28]
have been shown to infect cells of the epithelial lineage.
The presence of CAEV-infected epithelial cells in the
genital tract tissues could have a major impact on the
epidemiology of the disease. Infected epithelial cells
could maintain latent infection with no accompanying
inflammatory reaction; the embryo or fetus could there-
fore come into contact with CAEV during pregnancy and
be infected at different stages of development. This
would explain the presence of amplifiable CAEV
sequences in flushing media from superovulated does
[13,14] and in the post partum secretions of breeding
goats [10]. Even if the significance of intrauterine viral
transmission continues to be unclear and controversial
[29], infected epithelial cells could also explain the sero-
conversion in 2 of 32 kids delivered by caesarean section,
or 1 in 10 naturally born animals, all of which were colos-
trum-deprived [8]. In another instance, nearly a quarter
of kids separated from their mothers at birth had sero-
converted to CAEV by 5 months [30]. The related ovine
lentivirus has been shown to infect fetal lambs in utero
[31] and it has been estimated that this route could
account for 11% of contamination of lambs [32].
T h ep r e s e n c eo ft h eC A E Vg e n o m ei nt h eu t e r i n e
epithelial cells of does raises concerns regarding the risk
of CAEV transmission via embryo transfer. After in vitro
fertilization, early stage embryos are cultured on a feeder
layer of epithelial cells from goat oviducts [33-35], which
are essential for early development before transfer to
recipient does [36,37]. These cells are derived from
organs obtained at the slaughterhouse from goats of
unknown CAEV status, and in many industrialized coun-
tries the incidence of CAEV infection may be as high as
60 to 80% [6]. A similar instance occurred in bovine
embryo biotechnology, where feeder cells were found to
carry bovine viral diarrhea virus from contaminated
donors [38], which eventually infected embryos [39]. The
risk of embryo contamination by CAEV would seem,
however, to be limited, provided that the guidelines of
the International Embryo Transfer Society [40], are fol-
lowed strictly, because an intact zona pellucida has been
shown to protect against CAEV infection [14,41].
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